Explainer Semaglutide slowed measures of biological aging in a small trial
Researchers reanalyzed a 32-week trial of semaglutide in 84 adults and found the drug slowed several DNA-based clocks of biological aging. The aging analysis was exploratory, and the group studied was specific.
Jul 17, 2026
